Highly sensitive droplet digital polymerase chain reaction for BCR::ABL1 messenger RNA identifies patients with chronic myeloid leukaemia with a low probability of achieving treatment-free remission

Liu Lu, Chung Hoow Kok, Phuong Dang, Susan Branford, Verity A. Saunders, Naranie Shanmuganathan, David M. Ross, Timothy P. Hughes, David T.O. Yeung

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)600-603
Number of pages4
JournalBritish Journal of Haematology
Issue number3
Publication statusPublished or Issued - Aug 2022


  • BCR::ABL1
  • chronic myeloid leukaemia
  • ddPCR
  • measurable residual disease
  • treatment-free remission

ASJC Scopus subject areas

  • Hematology

Cite this